Phase Genomics launches ProxiMeta Starter and Elite bundles to expand access to Hi-C microbiome sequencing tools

Phase Genomics, Inc., a privately held genomic technology innovator based in Seattle, announced the launch of its new ProxiMeta™ Starter and Elite Bundles on June 19, 2025. These newly developed offerings are aimed at expanding access to Hi-C based metagenomics, making genome-resolved sequencing and microbial community analysis more feasible for laboratories across human microbiome, environmental, and public health research domains. Built on the company’s award-winning Hi-C platform, the new bundles reflect Phase Genomics’ continued commitment to transforming microbiome research through scalable, full-service genomics tools.

Founded in 2015, Phase Genomics has played a central role in popularizing proximity-ligation methods for sequencing applications. The firm’s ProxiMeta platform has been cited in numerous peer-reviewed publications for its ability to recover near-complete genomes from complex microbial environments while linking mobile genetic elements like plasmids and phages to their host organisms.

How do the new ProxiMeta bundles lower cost and technical barriers in genome-resolved metagenomics?

The ProxiMeta Starter and Elite Bundles were specifically developed to address gaps in accessibility within next-generation metagenomic workflows. As Hi-C sequencing becomes increasingly crucial for uncovering detailed genomic relationships in microbial ecosystems, Phase Genomics has recognized the need to simplify entry points for both early-stage researchers and advanced labs operating under capacity constraints.

The ProxiMeta Starter Bundle is positioned as an entry-level product tailored to new users with limited experience in high-resolution sequencing. It provides a pathway to Hi-C metagenomics for up to two samples and comes with a guarantee for successful library preparation. If initial prep fails, Phase Genomics will reprocess the sample at no additional charge. This model includes one-on-one support from Phase Genomics scientists, making it particularly appealing for graduate students, postdoctoral researchers, and new academic labs entering the field.

On the other end of the spectrum, the ProxiMeta Elite Bundle caters to established investigators managing large-scale studies. This bundle supports up to eight samples and includes end-to-end service—including deep shotgun sequencing and Hi-C scaffolding—conducted entirely in-house by Phase Genomics. The Elite option is effectively a remote extension of the user’s laboratory, removing the need for in-house sequencing infrastructure and specialized staff.

Institutional sentiment suggests these bundling strategies may significantly broaden the market for Hi-C sequencing applications. Analysts note that many research labs—especially those funded through grants or constrained by post-pandemic budgets—are seeking hybrid outsourcing models that allow them to retain scientific control while mitigating operational bottlenecks. The modular structure of the ProxiMeta bundles appears aligned with this demand trend.

Why is Hi-C sequencing considered essential for modern microbiome and environmental genomics?

Traditional metagenomic approaches often rely on 16S rRNA sequencing or culturing techniques, which lack the resolution to differentiate strains or link mobile elements to hosts. Hi-C metagenomics, by contrast, uses chromatin conformation capture to physically link DNA segments from the same microbial cell. This allows for high-confidence genome binning and the recovery of near-complete microbial genomes even in mixed or uncultivable samples.

The ProxiMeta platform developed by Phase Genomics has become a cornerstone in the field, recognized for its ability to generate genome-resolved insights at unprecedented scale. It has been cited in studies involving environmental monitoring, antimicrobial resistance tracking, and human microbiome research. By combining Hi-C data with metagenomic shotgun sequencing, the platform enables both structural resolution and functional annotation of microbial communities.

The release of the Starter and Elite Bundles thus opens new possibilities for investigators in fields ranging from wastewater epidemiology and agricultural soil microbiology to hospital-based pathogen surveillance and synthetic biology.

How does the ProxiMeta product line compare to existing market solutions for genome-resolved metagenomics?

Beyond the newly introduced bundles, Phase Genomics continues to offer its original ProxiMeta Classic format, an à la carte service for labs that prefer to manage sequencing workflows internally. ProxiMeta Classic provides flexibility for experienced users who already have access to wet lab or computational infrastructure but still wish to leverage Phase Genomics’ Hi-C capabilities.

All three offerings—Starter, Elite, and Classic—deliver access to the same proprietary reagents and bioinformatics pipeline, but differ in delivery model and scope. The Starter Bundle is suited for small pilot studies, the Elite Bundle targets high-throughput projects with limited bench resources, and the Classic version supports fully customized workflows.

The launch of these tiered service bundles reflects a broader trend in the genomics services industry. As sequencing costs continue to decline, many firms are shifting focus toward offering platform-as-a-service models, packaging reagents, computational pipelines, and expert support into unified products. Industry observers suggest that such models could drive faster turnaround times and better quality control, particularly in distributed or collaborative research settings.

What do institutional users and market observers expect from Phase Genomics’ metagenomic strategy?

Though Phase Genomics is not publicly listed and does not disclose revenue figures, institutional sentiment suggests the firm is well-positioned to benefit from increased federal and academic funding into microbiome and antimicrobial resistance research. The American biotech company’s growing reputation in applied metagenomics—combined with its turnkey offerings—has made it a trusted partner for consortia-based studies and public health surveillance initiatives.

Some analysts speculate that Phase Genomics could become a strategic acquisition target or key collaborator for large sequencing providers or bioinformatics firms looking to expand their footprint in microbial genomics. While no such activity has been publicly disclosed, the trend toward consolidation in genomics tools suggests that firms with unique technological assets—such as proximity ligation IP—may draw increasing interest.

In the short term, the ProxiMeta bundles are expected to increase order volumes from mid-sized research institutions and startup biotech firms, which often lack the capacity to build in-house sequencing teams. The inclusion of hands-on support, guaranteed success on library prep, and fully managed analysis workflows addresses core pain points voiced by many potential customers in academic, government, and industrial research.

Where and when are the new ProxiMeta bundles available, and how are they being promoted?

Phase Genomics began offering both the ProxiMeta Starter and Elite Bundles on June 19, 2025. Interested researchers can obtain more information or request consultations through the company’s official product landing page. Additionally, Phase Genomics is showcasing the new bundles at booth 1109 during the American Society for Microbiology’s ASM Microbe 2025 conference.

To engage the broader scientific community, the American genomics company has launched a targeted outreach campaign across social media, especially X (formerly Twitter) and LinkedIn. The company plans to release case studies and user success stories in Q3 2025, reinforcing product-market fit and scientific validity.

What is the future roadmap for Phase Genomics in genome assembly and metagenomics?

Looking ahead, analysts expect Phase Genomics to expand its ProxiMeta platform beyond research into clinical, agricultural, and industrial markets. Potential near-term developments may include regulatory-compliant kits for diagnostic applications, enhanced software pipelines with AI-driven binning, and partnerships to integrate Hi-C data into broader multi-omics platforms.

Given growing global concerns around microbial resistance, pathogen emergence, and environmental biodiversity loss, tools that offer complete genomic visibility are increasingly seen as foundational for strategic decision-making in both public and private sectors. The continued refinement of ProxiMeta—through new bundles and advanced analytics—positions Phase Genomics as a leading enabler of that transformation.